Learning from PD-1 Resistance: New Combination Strategies: Trends in Molecular Medicine
Soluble PD-L1 in blood correlates positively with neutrophil and negatively with lymphocyte mRNA markers and implies adverse sepsis outcome | Immunologic Research
Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy | PNAS
PD-1-high TILs: a predictive biomarker for ICB in lung cancer
Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancer - eBioMedicine
PD-1 Is a Selective Marker of Human Follicular T Cells (A)... | Download Scientific Diagram
Immunofluorescent stainings of PD-1, PD-L1 and myeloid markers.... | Download Scientific Diagram
Exhausted CD4⁺ T cell phenotype. Representative (n = 6) flow cytometry... | Download Scientific Diagram
Frontiers | Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
Coexpression of PD-1, NFB activation, and proliferation marker in... | Download Scientific Diagram
Repurposing Ponatinib as a PD-L1 Inhibitor Revealed by Drug Repurposing Screening and Validation by In Vitro and In Vivo Experiments | ACS Pharmacology & Translational Science
The diverse functions of the PD1 inhibitory pathway | Nature Reviews Immunology
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape | Molecular Cancer | Full Text
Predictive Markers for the Efficacy of Anti–PD-1/PD-L1 Antibodies in Lung Cancer - ScienceDirect
Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review)
Frontiers | Cancer Cell-Intrinsic PD-1 and Implications in Combinatorial Immunotherapy
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies | Nature Immunology
5-Jahresdaten Firstline Pembrolizumab plus R-CHOP beim DLBCL: Dauerhaftes Ansprechen, PD-L1-Expression prädiktiver Marker - onkologie heute
High IL-8 correlates with reduced response to PD-1/PD-L1 checkpoint blockade
Cancers | Free Full-Text | Immunotherapy Predictive Molecular Markers in Advanced Gastroesophageal Cancer: MSI and Beyond
Identification and Validation of a PD-L1 Binding Peptide for Determination of PDL1 Expression in Tumors | Scientific Reports
PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity | Nature Communications
